Correlation Between Meta Platforms and Rakovina Therapeutics

Can any of the company-specific risk be diversified away by investing in both Meta Platforms and Rakovina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Meta Platforms and Rakovina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Meta Platforms CDR and Rakovina Therapeutics, you can compare the effects of market volatilities on Meta Platforms and Rakovina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Meta Platforms with a short position of Rakovina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Meta Platforms and Rakovina Therapeutics.

Diversification Opportunities for Meta Platforms and Rakovina Therapeutics

0.74

Correlation Coefficient

Meta Platforms  Rakovina Therapeutics

Poor diversification

The 3 months correlation between Meta and Rakovina is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Meta Platforms CDR and Rakovina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rakovina Therapeutics and Meta Platforms is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Meta Platforms CDR are associated (or correlated) with Rakovina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rakovina Therapeutics has no effect on the direction of Meta Platforms i.e., Meta Platforms and Rakovina Therapeutics go up and down completely randomly.

Pair Corralation between Meta Platforms and Rakovina Therapeutics

Assuming the 90 days trading horizon Meta Platforms is expected to generate 1.82 times less return on investment than Rakovina Therapeutics. But when comparing it to its historical volatility, Meta Platforms CDR is 4.54 times less risky than Rakovina Therapeutics. It trades about 0.25 of its potential returns per unit of risk. Rakovina Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  50.00  in Rakovina Therapeutics on April 24, 2025 and sell it today you would earn a total of  18.00  from holding Rakovina Therapeutics or generate 36.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.41%
Values	Daily Returns

Meta Platforms CDR  vs.  Rakovina Therapeutics

Meta Platforms CDR

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Meta Platforms CDR are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of rather abnormal technical and fundamental indicators, Meta Platforms exhibited solid returns over the last few months and may actually be approaching a breakup point.

Rakovina Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Rakovina Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Rakovina Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Meta Platforms and Rakovina Therapeutics

The main advantage of trading using opposite Meta Platforms and Rakovina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Meta Platforms position performs unexpectedly, Rakovina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rakovina Therapeutics will offset losses from the drop in Rakovina Therapeutics' long position.

The idea behind Meta Platforms CDR and Rakovina Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..